Possible involvement of glycogen phosphorylase of brain in the affective states.
D000661:Amphetamine / Q000494:pharmacology; D000818:Animals; D000928:Antidepressive Agents / Q000494:pharmacology; D001921:Brain / Q000187:drug effects / Q000201:enzymology*; D002746:Chlorpromazine / Q000494:pharmacology; D003863:Depression / Q000201:enzymology*; D003891:Desipramine / Q000494:pharmacology; D004347:Drug Interactions; D005260:Female; D006801:Humans; D007490:Iproniazid / Q000494:pharmacology; D010293:Pargyline / Q000494:pharmacology; D010640:Phenothiazines / Q000494:pharmacology; D006005:Phosphorylases / Q000378:metabolism*; D011346:Prochlorperazine / Q000494:pharmacology; D011395:Promazine / Q000494:pharmacology; D011398:Promethazine / Q000494:pharmacology; D051381:Rats; D011941:Receptors, Adrenergic; D012110:Reserpine / Q000494:pharmacology; D013237:Stereoisomerism; D014149:Tranquilizing Agents / Q000494:pharmacology
D000928:Antidepressive Agents; D010640:Phenothiazines; D011941:Receptors, Adrenergic; D014149:Tranquilizing Agents; D012110:Reserpine; D010293:Pargyline; D000661:Amphetamine; D007490:Iproniazid; D006005:Phosphorylases; D011398:Promethazine; D011395:Promazine; D003891:Desipramine; D002746:Chlorpromazine; D011346:Prochlorperazine